Cor triatriatum medical therapy: Difference between revisions
(New page: {{Cor triatriatum}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, M.B.B.S. [mailto:psingh@perfuse.org]; {{CZ}}; Keri Shafer, M.D. [m...) |
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Cor triatriatum}} | {{Cor triatriatum}} | ||
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto: | {{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{CZ}}; [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu] | ||
==Overview== | ==Overview== | ||
| Line 15: | Line 15: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
Latest revision as of 13:44, 2 November 2012
|
Cor triatriatum Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Cor triatriatum medical therapy On the Web |
|
American Roentgen Ray Society Images of Cor triatriatum medical therapy |
|
Risk calculators and risk factors for Cor triatriatum medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
Overview
In cor triatriatum, adminstration of effective medical therapy in a timely manner can serve as a supplementary, supportive measure prior to surgical therapy. Medical therapy measures should focus on addresses various complication complexes and preventing further complications from developing prior to surgery.
Medical therapy
Medical therapy is primarily supportive to manage pulmonary venous congestion until surgical resection can be performed.
Commonly, medical therapy includes:
- Hemodynamic stabilization via manipulation of hypoxemia, pulmonary congestion and fluid overload
- Use of anticoagulants and anticoagulant prophylaxis to serve as a preventative measure in right-sided heart failure patients prone to deep vein thrombosis and pulmonary embolization
- Control and stablization of ventricular rate in patients with a support atrial fibrillation complex
- Use of medication to control fluid retention and the rate-control of arrhythmias